Histopathological classification (n) | Deformability | SWV (m/s) (mean ± SD) |
---|---|---|
Sebaceous adenoma (6) | Deformable 16.7% Non-deformable 83.3% | 3.82 ± 1.92 |
Basal cell carcinoma (2) | Deformable 0% Non-deformable 100% | 3.87 ± 1.84 |
Squamous cell carcinoma (15) | Deformable 0% Non-deformable 100% | 3.82 ± 1.96 |
Mixed carcinoma (2) | Deformable 0% Non-deformable 100% | 2.46 ± 0.19 |
Apocrine cystadenoma (2) | Deformable 0% Non-deformable 100% | 3.72 ± 1.81 |
Fibrosarcoma (4) | Deformable 0% Non-deformable 100% | 3.89 ± 1.88 |
Cavernous hemangioma (6) | Deformable 0% Non-deformable 100% | 3.87 ± 1.79 |
Hemangiosarcoma (5) | Deformable 20% Non-deformable 80% | 2.9 ± 1.97 |
Cutaneous lymphoma (13) | Deformable 0% Non-deformable 100% | 3.6 ± 1.97 |
Lipoma (17) | Deformable 64.7% Non-deformable 35.3% | 3.83 ± 1.84 |
High-grade cutaneous mast cell tumor (24) | Deformable 4.2% Non-deformable 95.3% | 3.76 ± 1.92 |
Low-grade cutaneous mast cell tumor (10) | Deformable 0% Non-deformable 100% | 3.91 ± 1.79 |
Infiltrative subcutaneous mast cell tumor (2) | Deformable 0% Non-deformable 100% | 3.96 ± 1.83 |
Amelanotic melanoma (9) | Deformable 0% Non-deformable 100% | 3.72 ± 1.83 |
Grade II soft tissue sarcoma (7) | Deformable 0% Non-deformable 100% | 3.67 ± 1.8 |